
PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years
An analysis was performed on real-world outcomes of U.S. Medicare beneficiaries >60 years old with presumed PFO-associated stroke implanted with the Amplatzer™ PFO Occluder or the Amplatzer™ Talisman™ PFO Occluder.
Related Resources

ESOC presentation: PFO closure in patients > 60 Years

TRILUMINATE Pivotal - 2-year update EuroPCR 25

Talisman™ vs Occlutech‡ Clinical Insights

Epic Mitral – 10-Year Clinical Outcomes

Clinical trial summary: Piccolo™

Amplatzer™ Amulet™ LAA Occluder

Amplatzer™ Septal Occluder (ASO) brochure

Clinical insights: Patients with PFO